Financial Information | Regeneron Pharmaceuticals Inc.

Filing date	Form	Description	View
Aug 01, 2024	144	Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing	View HTML 0001968582-24-000646.pdf 0001968582-24-000646.xls
Aug 01, 2024	144	Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing	View HTML 0001950047-24-005730.pdf 0001950047-24-005730.xls
Aug 01, 2024	CORRESP	CORRESP	View HTML 0001804220-24-000031.pdf 0001804220-24-000031.xls
Jul 22, 2024	UPLOAD	UPLOAD	View HTML 0000000000-24-008276.pdf
Jul 12, 2024	4	Statement of changes in beneficial ownership of securities	View HTML 0001968202-24-000107.pdf 0001968202-24-000107.xls
Jul 08, 2024	8-K	Report of unscheduled material events or corporate event	View HTML 0001104659-24-078172.pdf 0001104659-24-078172.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
Jul 02, 2024	4	Statement of changes in beneficial ownership of securities	View HTML 0001968202-24-000106.pdf 0001968202-24-000106.xls
Jul 02, 2024	4	Statement of changes in beneficial ownership of securities	View HTML 0001968202-24-000105.pdf 0001968202-24-000105.xls
Jul 01, 2024	144	Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing	View HTML 0001950047-24-005174.pdf 0001950047-24-005174.xls
Jun 25, 2024	4	Statement of changes in beneficial ownership of securities	View HTML 0001883850-24-000037.pdf 0001883850-24-000037.xls

Data provided by Kaleidoscope.

Investors & Media